Quarterly report pursuant to Section 13 or 15(d)

COMMON STOCK

v3.22.2.2
COMMON STOCK
6 Months Ended
Jun. 30, 2022
Equity [Abstract]  
COMMON STOCK

9. COMMON STOCK

 

The Company’s common stock activity for the six months ended June 30, 2022, was as follows:

 

During the six months ended June 30, 2022, the Company issued 14,666,667 shares of common stock as part of a Registered Direct Offering, which resulted in proceeds of $10,242, net of offering costs of $758.

 

During the six months ended June 30, 2022, the Company issued 11,096,683 shares of common stock pursuant to the Common Stock Purchase Agreement, which resulted in proceeds of $9,836, net of offering costs of $197. In addition, the Company issued 607,287 shares of common stock as a commitment fee in connection with the consummation of the transactions contemplated by the Common Stock Purchase Agreement.

 

 

During the six months ended June 30, 2022, the Company issued 1,291,300 shares of common stock to certain employees and vendors for services rendered and to be rendered with an aggregate grant date fair value of $1,148. These shares of common stock were valued based on the closing price of the Company’s common stock on the date of the issuance or the date the Company entered into the agreement related to the issuance.

 

During the six months ended June 30, 2022, the Company issued 189,394 shares of common stock to the Company’s Chief Executive Officer in lieu of the cash payment of a bonus accrued in a prior year, with an aggregate grant date fair value of $100 based on the closing price of the Company’s common stock on the date of issuance.

 

The Company also issued 227,136 shares of common stock to the Company’s former Chief Financial Officer as part of a separation agreement, with an aggregate grant date fair value of $277 based on the closing price of the Company’s common stock on the date of issuance.

 

During the six months ended June 30, 2022, the Company issued 463,234 shares of common stock to certain officers, employees and directors associated with the vesting of restricted stock units.